We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
Birdsboro Steel & Foundry
(Site Profile/Docket Number 070)
Location: Birdsboro, Pennsylvania
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
There are no current active petitions for Birdsboro Steel & Foundry.
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile for Atomic Weapons Employers that Worked Uranium Metals [944 KB (55 pages)]
Revised June 17, 2011
Previously titled “Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals”
About this Document: This document provides an exposure matrix for workers at AWE facilities that performed metal-working operations with uranium metal. Over 110 facilities performed these operations, and this document intends to provide guidance for dose reconstruction at any of these facilities. The main body of this document, in Sections 2-6, includes general discussions of operations and exposure conditions at these facilities. Following the main body of this document is a collection of appendices, with one appendix for each AWE site that performed metal-working operations. Each appendix contains site-specific information that can be used for dose reconstruction. For those sites where this information is insufficient or totally lacking, the dose reconstructor must use information in the main body of the Site Profile.
Revision Includes: Incorporates review comments. Added external beta dose from surface contamination. Expanded discussion in section 3.3.1. Additional editorial changes and typographical error corrections.
Appendix B — Birdsboro Steel & Foundry Company [192 KB (8 pages)]
Revised June 2, 2015
Advisory Board and NIOSH Discussions on Birdsboro Steel & Foundry
The Birdsboro Steel & Foundry discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
NIOSH/DCAS Memo: NIOSH DCAS response to SC&A review of DCAS-PER-073 “Birdsboro Steel and Foundry Company” Finding 1 [463 KB (11 pages)]
September 2, 2022
SC&A Handout: Carryover Items from February 2019 and 2021 SCPR Meetings [661 KB (8 pages)]
Discussion/Background Paper at the May 25, 2022, Teleconference Meeting of the Subcommittee for Procedure Reviews
SC&A Presentation: Review of DCAS-PER-073 – Birdsboro Steel Foundry and Machine Company [227 KB (15 pages)]
(Presentation at the February 13, 2019, Teleconference Meeting of the Subcommittee for Procedures Review)
SC&A Draft: A Review of NIOSH’s Program Evaluation Report DCAS-PER-073, “Birdsboro Steel and Foundry Company” [188 KB (25 pages)]
Contract No. 211-2014-58081
SCA-TR-2018-PR003, Revision 0
June 7, 2018
Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
DCAS-PER-073, Rev. 0: Birdsboro Steel and Foundry Company Program Evaluation Report [75 KB (2 pages)]
August 1, 2016
About this Document: Determines the effect of the revision to Appendix B of Battelle-TBD-6000 (Birdsboro) on previously completed claims.
Summary: The resulting probability of causation (POC) was below 45% for all effected claims. NIOSH will provide the Department of Labor with the list of all claims evaluated under this PER. Since none would now result in a POC greater than 50%, NOSH will not request the return of any of the claims.
Public Comments on Birdsboro Steel & Foundry Documents
How to Submit Comments
Comments on Birdsboro Steel & Foundry Documents can be submitted to the NIOSH Docket Officer electronically by email at firstname.lastname@example.org or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (070) on all comments.
At this time, no comments have been submitted.